Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tirzepatide activates two appetite pathways simultaneously, making it approximately twice as effective for weight loss in clinical trialspatients on tirzepatide lose 2022% body weight versus 1517% on semaglutide over 68 weeks
This ensures safe treatment
The trial record can be viewed through the official ClinicalTrials.gov MOTS-C study page
This medicine is used to treat vitamin B12 deficiency caused by poor absorption, including pernicious anemia and certain stomach, intestinal, or surgical conditions
US$ 20.26
US$ 23.32
US$ 25.53
